Xfinito Biodesigns is focused on building its patent-pending AI platform, Xeuron.ai, which utilizes feedback from Neurons and Muscles to disrupt various consumer segments such as Deeptech research, Diseases Management, Rare Diseases, Mental Health, and Gaming. The platform aims to tap into the potential of Neurotechnology for consumers, researchers, hobbyists, and developers. Additionally, Xfinito Biodesigns plans to launch Medical Devices in the neurodegenerative segment, targeting diseases like Parkinson's, Neuropathy, and Muscular Dystrophy. The company's solution aims to improve the management of neurological disorders, support clinicians in treatment monitoring, and potentially reduce disability caused by neurodegeneration.